You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 23, June 17, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Metabolism
 •Renal Diseases
 •Dialysis
 •Renal Diseases, Other
 •Diet
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: As Dr Lopes and Ms Lopes point out, restricting dietary phosphorus intake may be associated with unacceptable declines in protein intake. This may occur because many foods that are naturally high in phosphorus, such as meats, dairy products, beans, and nuts, are also important protein sources. However, the widespread use of phosphorus-containing food additives, especially in low-protein products such as baked goods and beverages, has weakened the link between phosphorus and protein intake. Therefore, avoiding baked goods and beverages that contain phosphorus additives should have little effect on protein intake.

Moreover, we instructed our intervention participants to select protein foods that did not contain phosphorus additives at grocery stores and fast food restaurants. We did not measure protein nitrogen appearance as part of our clinical trial. However, there were no differences between intervention and control patients at the beginning or the end of the trial in postdialysis weight, . . . [Full Text of this Article]

Ashwini R. Sehgal, MD
sehgal@case.edu

Catherine Sullivan, MS, RD, LD; Srilekha S. Sayre, MS, RD, LD
Division of Nephrology
MetroHealth Medical Center
Cleveland, Ohio



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease: A Randomized Controlled Trial
Catherine Sullivan, Srilekha S. Sayre, Janeen B. Leon, Rhoderick Machekano, Thomas E. Love, David Porter, Marquisha Marbury, and Ashwini R. Sehgal
JAMA. 2009;301(6):629-635.
ABSTRACT | FULL TEXT  

RELATED LETTER

Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease
Antonio Alberto Lopes and Gildete Barreto Lopes
JAMA. 2009;301(23):2443-2444.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.